Overview
- FIS said there is no indication or proof that competitors used hyaluronic acid injections to alter suit fit for performance gains.
- The allegation originated in a Bild report suggesting some athletes injected the substance or used a protective device to influence pre-measurement sizing.
- WADA Director-General Olivier Niggli said the agency would analyze any credible evidence if it emerged and related to doping.
- WADA spokesperson James Fitzgerald clarified that hyaluronic acid is not on the prohibited list and referred suit questions to FIS.
- The controversy follows last year’s Norwegian suit-tampering scandal that led to bans and prompted FIS to tighten checks with pre- and post-jump inspections, enhanced 3D measurements, and suit microchips.